CorPath GRX System— 510(k) K221464

Substantially Equivalent

Corindus, Inc.

FDA 510(k) clearance K221464 for CorPath GRX System, Substantially Equivalent on 2022-07-27. Applicant: Corindus, Inc..

Clearance details

Applicant: Corindus, Inc.
Product code: Code DXX
Advisory panel: Cardiovascular
Date received: 2022-05-19
Decision date: 2022-07-27
Decision: Substantially Equivalent
Clearance type: Special
Location: Waltham, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.